setrusumab

Biotech Mereo BioPharma pens $50M Ultragenyx deal for rare bone disease drug
Fierce Biotech
Fri, 12/18/20 - 11:41 am
Mereo BioPharma
Ultragenyx
setrusumab
osteogenesis imperfecta
Mereo’s brittle bone drug likely to shrug off phase 2b fail, say analysts
Pharmaforum
Sat, 11/30/19 - 11:01 pm
Mereo BioPharma
clinical trials
brittle bone disease
setrusumab
UK biotech Mereo gears up for key brittle bone drug data
Pharmaforum
Thu, 05/2/19 - 11:15 am
Mereo BioPharma
brittle bone disease
osteogenesis imperfecta
setrusumab